Autologous bone marrow-derived mesenchymal stem cells for interstitial fibrosis and tubular atrophy: a pilot study
CONCLUSION: Our results demonstrated that autologous BM-MSCs are safe and beneficial for IFTA patients. Abbreviations: MSCs: mesenchymal stem cells; BM-MSCs: marrow-derived mesenchymal stem cells; IFTA: interstitial fibrosis and tubular atrophy; CAN: chronic allograft nephropathy; CNIs: calcineurin inhibitors; Scr: serum creatinine; CCr: creatinine clearance rate; Cys-C: cystatin-C; TGF-β1: transforming growth factor β1; CTGF: connective tissue growth factor.PMID:34493167 | DOI:10.1080/0886022X.2021.1968432
Source: Renal Failure - Category: Urology & Nephrology Authors: Lei Zhang Xingqiang Lai Yuhe Guo Junjie Ma Jiali Fang Guanghui Li Lu Xu Wei Yin Zheng Chen Source Type: research
More News: Allergy | Allergy & Immunology | Bone Graft | Renal Failure | Stem Cell Therapy | Stem Cells | Study | Transplants | Urology & Nephrology